CRP and inflammatory bowel disease: Contrary results were reported in a study conducted by Tran et al. [26], what brought to the conclusion that the circulating LL-37 level may be useful as a non-invasive predictor of mucosal damage when co-assessed with C-reactive protein in UC patients, a predictor of stricturing pattern of CD and an indicator of a better prognosis in IBD overall.